Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience
Author(s) -
Nilay Danış,
Hüsnü Pullukçu,
Tansu Yamazhan,
Galip Ersöz,
Nalan Gülşen Ünal,
Fulya Günşar,
İlker Turan,
Zeki Karasu,
Ulus Salih Akarca
Publication year - 2019
Publication title -
the turkish journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 28
eISSN - 2148-5607
pISSN - 1300-4948
DOI - 10.5152/tjg.2019.09
Subject(s) - medicine , ombitasvir , dasabuvir , ribavirin , ritonavir , paritaprevir , hemodialysis , virology , chronic hepatitis , viral load , human immunodeficiency virus (hiv) , virus , antiretroviral therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom